Clinical Trials Directory

Trials / Unknown

UnknownNCT04604756

The Effects of Losartan on Social Reward

Losartan Effects on the Social Reward in Humans

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate the effect of losartan (50mg, single dose) on social reward

Detailed description

In a double-blind, between-subject, placebo-controlled design the effects of a single dose of losartan (50mg) on social reward in healthy participants will be examined. 90 minutes after subjects administrate 50mg losartan or placebo, participants will undergo a social incentive delay task. Neural activity will be assessed by the acquisition of functional magnetic resonance imaging (fMRI) data.

Conditions

Interventions

TypeNameDescription
DRUGLosartanadministration of losartan (50 mg) (oral)
DRUGPlacebo Oral Tabletadministration of placebo (oral)

Timeline

Start date
2020-10-10
Primary completion
2021-12-31
Completion
2022-03-31
First posted
2020-10-27
Last updated
2020-10-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04604756. Inclusion in this directory is not an endorsement.